Molecular Imaging of the inflammatory-fibrosis axis in LV remodeling.

“We envision that molecular imaging will offer unprecedented insights into the natural history of cardiac inflammation and fibrosis, enhance crosstalk between bench and bedside, provide paradigm-shifting diagnostic tools to assign patient prognosis, and safely enable precise implementation of therapeutics targeting the inflammatory-fibrosis axis.”
Dr. Robert Gropler, Washington University School of Medicine, Lead Coordinator- Imaging Initiative